Comparing Rituximab vs Venclexta
Rituximab | Venclexta |
|
---|
Rituximab | Venclexta (venetoclax) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Rituximab (brand name Rituxan) is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia... View more |
Prescription only
Venclexta is a BCL-2 inhibitor that may be used to treat chronic lymphocytic leukemia (CLL), small cell lymphoma (SCL), or acute myeloid leukemia. It is an oral tablet that is administered once... View more |
Related suggestions Chronic Lymphocytic Leukemia
|
|||||||
More about Rituximab | More about Venclexta (venetoclax) | ||||||||
Ratings & Reviews | |||||||||
Rituximab has an average rating of 7.7 out of 10 from a total of 154 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 14% reported a negative effect. |
Venclexta has an average rating of 8.3 out of 10 from a total of 7 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: rituximab side effects in more detail. |
See also: Venclexta side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Venclexta prices |
||||||||
Dosage Forms Available | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Riabni, Rituxan, Ruxience, Truxima |
N/A |
||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
59.8 hours |
26 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 164 drugs are known to interact with rituximab:
|
A total of 423 drugs are known to interact with Venclexta:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
April 11, 2016 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.